# Pharmacogenetics in Primary Care Psychotropics

> **NCT03232502** · PHASE3 · UNKNOWN · sponsor: **University of Arizona** · enrollment: 130 (estimated)

## Conditions studied

- Depression
- Obsessive-Compulsive Disorder
- Generalized Anxiety Disorder

## Interventions

- **DIAGNOSTIC_TEST:** Pharmacogenetic testing

## Key facts

- **NCT ID:** NCT03232502
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-15
- **Primary completion:** 2018-01-15
- **Final completion:** 2018-12-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03232502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03232502, "Pharmacogenetics in Primary Care Psychotropics". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03232502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*